Serum CA 125, CA 15-3, CEA, and CA 19-9: a prognostic factor for uterine carcinosarcomas?

被引：0
|
作者：
Nikolaos Thomakos
Alexandros Rodolakis
Flora Zagouri
Dimitrios Zacharakis
Maria Sotiropoulou
Nikolaos Akrivos
Dimitrios Haidopoulos
Christos A. Papadimitriou
Meletios-Athanassios Dimopoulos
Aris Antsaklis
机构：
[1] University of Athens,Department of Obstetrics and Gynecology, Alexandra Hospital, School of Medicine
[2] University of Athens,Department of Clinical and Therapeutics, Alexandra Hospital, School of Medicine
[3] Alexandra Hospital,Department of Pathology
来源：
Archives of Gynecology and Obstetrics | 2013年 / 287卷
关键词：
CEA; CA 125; CA 19-9; CA 15-3; Serum; Uterine carcinosarcoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：97 / 102
页数：5
相关论文
共 50 条
  • [21] Diagnostic value of Cyfra 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assay in pleural effusions: Analysis of 116 cases and review of the literature
    Shitrit, D
    Kramer, M
    Zingerman, B
    Shlomi, D
    Bargil-Shitrit, A
    LUNG CANCER, 2005, 49 : S162 - S162
  • [22] Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: Analysis of 116 cases and review of the literature
    Shitrit, D
    Zingerman, B
    Shitrit, ABG
    Shlomi, D
    Kramer, MR
    ONCOLOGIST, 2005, 10 (07): : 501 - 507
  • [23] Correlation of histological grade of endometrial cancer with serum CA-125, CA 19-9, CEA and CA15.3
    Tsakiraki, Z.
    Pergaliotis, V.
    Zacharatou, A.
    Gouloumis, A-R.
    Panopoulou, E.
    Konstantoudakis, S.
    Pouliakis, A.
    Damaskou, V.
    VIRCHOWS ARCHIV, 2018, 473 : S259 - S259
  • [24] A multicentre evaluation of the CA 15-3 assay, CA 19-9 assay and CA 125 II assay on the Bayer Immuno 1(R) system
    Romer, M
    Haeckel, R
    Brux, B
    Sinha, P
    Raiko, I
    Krieg, M
    Stark, M
    Seidel, D
    Hubner, U
    Schmitz, G
    EUROPEAN JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1997, 35 (08): : 637 - 644
  • [25] Prevalence of CEA, CA 125, and CA 15-3 serum tumour markers in different regions of Saudi Arabia
    Ashi, Abrar
    Al-Hajeili, Marwan
    Almaghrabi, Sarah
    Al-Maghrabi, Jaudah
    Trabulsi, Nora
    Alghuraibi, Shmoukh
    Alsiary, Rawaih
    Alrayes, Nuha
    SAUDI MEDICAL JOURNAL, 2024, 45 (06) : 565 - 571
  • [26] Correlation Analysis of Baseline Serum CA 19-9, CEA, and CA 125 in Patients With Advanced Pancreatic Cancer
    Deng, G.
    Yan, H.
    Guo, Z.
    Dai, G.
    PANCREAS, 2020, 49 (10) : 1406 - 1406
  • [27] Establishment of ELISA on 384-well microplate for AFP, CEA, CA 19-9, CA 15-3, CA 125, and PSA-ACT: Higher sensitivity and lower reagent cost
    Wu, TL
    Sun, YC
    Chang, PY
    Tsao, KC
    Sun, CF
    Wu, JT
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2003, 17 (06) : 241 - 246
  • [28] Serum CEA and CA 15-3 as prognostic factors in primary breast cancer
    F G Ebeling
    P Stieber
    M Untch
    D Nagel
    G E Konecny
    U M Schmitt
    A Fateh-Moghadam
    D Seidel
    British Journal of Cancer, 2002, 86 : 1217 - 1222
  • [29] Serum CEA and CA 15-3 as prognostic factors in primary breast cancer
    Ebeling, FG
    Stieber, P
    Untch, M
    Nagel, D
    Konecny, GE
    Schmitt, UM
    Fateh-Moghadam, A
    Seidel, D
    BRITISH JOURNAL OF CANCER, 2002, 86 (08) : 1217 - 1222
  • [30] IMMUNOASSAY OF CEA, CA 19-9, CA 125, AND CA 15-3 ON THE AUTOMATED SYSTEMS ES-300 AND ES-600 - METHODOLOGICAL EVALUATION FROM A MULTICENTER COLLABORATIVE STUDY
    ZUCCHELLI, GC
    PILO, A
    JAWOREK, D
    MASINI, S
    CHIESA, MR
    EUROPEAN JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1992, 30 (12): : 875 - 879
12345